The problem with burning health insurance down
Let ’s burn health insurance down. Greedy corporate bastards should burn. Big Pharma and big hospitals should probably burn too. You know who else is really, really, bad? Wall Street. Let’s burn the banks. And let’s burn Big Tech and the entire Silicon Valley cartel. Let’s also burn Big Agribusi ness that’s making us fat and sick. […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - May 16, 2019 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/margalit-gur-arie" rel="tag" > Margalit Gur-Arie < /a > < /span > Tags: Policy Public Health & Washington Watch Source Type: blogs

Options to Opioids: How to Manage Chronic Pain Without Prescribing Pain-Killers
You're reading Options to Opioids: How to Manage Chronic Pain Without Prescribing Pain-Killers, originally posted on Pick the Brain | Motivation and Self Improvement. If you're enjoying this, please visit our site for more inspirational articles. While there is considerable debate as to how much blame doctors should be assigned for the ongoing opioid crisis, there is little doubt they can do something to curtail it -- that instead of prescribing drugs that have been found to be highly addictive they can resort to alternate forms of pain management. Doctors’ prescription of powerful painkillers like OxyContin is frequ...
Source: PickTheBrain | Motivation and Self Improvement - May 14, 2019 Category: Consumer Health News Authors: DrStanleyMatthew Tags: health and fitness addiction health and wellness opioids self improvement Source Type: blogs

We Are Not A Dashboard: Contesting The Tyranny Of Metrics, Measurement, And Managerialism
By DAVID SHAYWITZ The dashboard is the potent symbol of our age. It offers the elegant visualization of data, and is intended to capture and represent the performance of a system, revealing at a glance current status, and pointing out potential emerging concerns. Dashboards are a prominent feature of most every “big data” project I can think of, offered by every vendor, and constructed to provide a powerful sense of control to the viewer. It seemed fitting that Novartis CEO Dr. Vas Narasimhan, a former McKinsey consultant, would build (then tweet enthusiastically about) “our new ‘contro...
Source: The Health Care Blog - May 13, 2019 Category: Consumer Health News Authors: Christina Liu Tags: Data Health Tech Big Data David Shaywitz Health Data Metrics Source Type: blogs

One Physician ’s Frustrations of Practicing Amidst the CHIPHIT Complex and Implications for the Future of the U.S. Healthcare System
By HAYWARD ZWERLING, MD The high cost, low quality and systemic inequities of the U.S. healthcare system have been the impetus for its redesign. Our healthcare system is now controlled by Consolidated Healthcare institutions, Insurance companies, Pharmaceutical companies and Health Information Technology companies (CHIPHIT complex). The CHIPHIT complex, along with the Federal Government, will create and control our future healthcare system. Ominously missing from this list are independent healthcare policy experts, independent healthcare providers and members of the general public. Historical precedents have demonst...
Source: The Health Care Blog - May 8, 2019 Category: Consumer Health News Authors: Christina Liu Tags: Health Policy Hayward Zwerling health inequities US Healthcare Source Type: blogs

Fight Aging! Newsletter, May 6th 2019
This study shows that mRNA levels of the aging related lamin A splice variant progerin, associated with premature aging in HGPS, were significantly upregulated in subjects with BMI ≥ 25 kg/m2. Moreover, our data revealed a significantly positive correlation of BMI with progerin mRNA. These data provide to our knowledge for the first-time evidence for a possible involvement of progerin in previously observed accelerated aging of overweight and obese individuals potentially limiting their longevity. Our results also showed that progerin mRNA was positively correlated with C-reactive protein (CRP). This might suggest an as...
Source: Fight Aging! - May 5, 2019 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

The Real Era of The Art of Medicine Begins With Artificial Intelligence
In spite of common fears and perceived dangers, artificial intelligence won’t take the jobs of physicians and won’t monopolize medicine. On the contrary: as A.I. will help automate administrative tasks and take over monotonous day-to-day assignments, it will free up time for medical professionals to finally fulfill the mission they signed up for: to help people on their journeys to health with compassion, creativity, and care. Moreover, rather than wiping it out, A.I. will, in fact, facilitate the art of medicine. Let us show it through the example of the AlphaGo documentary. Artificial intelligence and the ...
Source: The Medical Futurist - April 30, 2019 Category: Information Technology Authors: nora Tags: Artificial Intelligence in Medicine Future of Medicine AI algorithm art of medicine Health Healthcare medical smart smart algorithm technology Source Type: blogs

An Interview with Carolina Oliveira of OneSkin Technologies
OneSkin Technologies is one of the few companies in the present community of startups focused on rejuvenation and slowing aging to adopt a serious cosmetics focus on development. Here "cosmetics" is a regulatory term, not an indication of something used for the purposes of looks: it is perfectly possible for a topically applied product that is regulated as a cosmetic to have therapeutic effects, just like a drug. Nonetheless, cosmetics and drugs have entirely distinct paths of regulation, very different from one another, and each with their own costs and challenges. In regulated cosmetics development there is no ...
Source: Fight Aging! - April 29, 2019 Category: Research Authors: Reason Tags: Healthy Life Extension Community Source Type: blogs

Med-S2T (Skin-to-Thing) Solutions-The Critical and Challenging Pillar of Wearable Medical Devices
As technology transforms our life and our health, and healthcare trends are changing, more and more wearable devices are being developed by innovative and leading companies. Traditional medical devices are now being replaced by smart and versatile wearable devices which can collect data, analyze it, make diagnosis and take actions. This revolution is driven by the growing and aging population, the increase of chronic illness and the desire to improve life-quality and well-being of people all over the world. Such companies which are dealing with the development of a wearable medical device, are bringing the IoT (Internet of...
Source: Medgadget - April 25, 2019 Category: Medical Devices Authors: Edith Bianchi Tags: Sponsored Content Source Type: blogs

Monday 29 April 2019
Yes, that’s next Monday.  That’s four days away. It’s the day that the trial starts in the UK… I’m talking about the High Court action against GlaxoSmithKline that is being taken by a group of UK patients who are determined to finally have their day in court confronting GlaxoSmithKline. It has been a long slog with many false starts but we have finally, finally made it.  Over the years there were times I really did think that we would never get to court. But we have and I for one am ready. And this time GSK, it’s personal. Let’s shine a light under this pa...
Source: seroxat secrets... - April 25, 2019 Category: Addiction Authors: admin Tags: Big Pharma GSK Paxil Seroxat Source Type: blogs

Patient-Directed Access for Competition to Bend the Cost Curve
By ADRIAN GROPPER, MD Many of you have received the email: Microsoft HealthVault is shutting down. By some accounts, Microsoft has spent over $1 Billion on a valiant attempt to create a patient-centered health information system. They were not greedy. They adopted standards that I worked on for about a decade. They generously funded non-profit Patient Privacy Rights to create an innovative privacy policy in a green field situation. They invited trusted patient surrogates like the American Heart Association to participate in the launch. They stuck with it for almost a dozen years. They failed. The broken market and promi...
Source: The Health Care Blog - April 18, 2019 Category: Consumer Health News Authors: Christina Liu Tags: Economics Health Policy Health Technology Adrian Gropper CMS Health Data Interoperability ONC Source Type: blogs

My Trial With Sanofi's Admelog, The Biosimilar Version of Humalog
A while back Iblogged about the emergence of biosimilar insulin in the U.S., more than a decade after I studied the topic and discovered some troubling reasons none existed. Since then, in spite of top officials at the U.S. Department of Health and Human Services advocating for a more robust biosimilars market in the U.S., we have seen fewer rather than more, so that's not working out so well for the Trump Administration's promise to bring drug prices way down so far. In late 2018, Merck quietly pulled the plug on its own Lantus biosimilar which was to be branded as Lusduna Nexvue (see moreHERE for details). Merc...
Source: Scott's Web Log - April 9, 2019 Category: Endocrinology Tags: Eli Lilly and Company follow-on insulin analogs 2019 Admelog biosimilars generics Humalog insulin prices Medicare Sanofi Source Type: blogs

Investment State-of-Play in Big Pharma: Bayer ’s Eugene Borukhovich Weighs In
By JESSICA DaMASSA, WTF HEALTH Bayer’s G4A team launched their 2019 program today, so here’s a little help for anyone curious about the state of pharma startup investment and what it takes to land a deal there these days. I had the chance to pick the brain of Bayer’s Global Head of Digital Health, Eugene Borukhovich, during JP Morgan Healthcare Week and pulled out these three gloriously thought-provoking soundbites from our conversation to give you some insight as to the mindset over at big Bayer. “Digital therapeutics are shining light on the convoluted, complex mess of digital health&rd...
Source: The Health Care Blog - April 1, 2019 Category: Consumer Health News Authors: Christina Liu Tags: Health Tech Health Technology Jessica DaMassa Pharmaceuticals Start-Ups Bayer WTF Health Source Type: blogs

Custom Pill Bottles Thanks to E-Paper Labels
Labels on pill bottles are designed to give the patient the necessary information, such as the drug inside and how often to take it. Prescriptions change, though, and in some cases, such as clinical trials, the regimen can vary significantly from day to day. We recently learned of a relatively new product, an electronic screen for pill bottles, that can be changed whenever necessary without worrying that the batteries will run out. E Ink, a company that developed the kind of paper-like screens that are common in Amazon’s Kindles, partnered with Faubel, a pharma packaging and labeling company, to release the Faubel-Me...
Source: Medgadget - March 26, 2019 Category: Medical Devices Authors: Editors Tags: Geriatrics Medicine Public Health Source Type: blogs

The Most Pressing Issues In Bioethics
Who owns medical and genetic data? How to regulate gene editing? Where is the boundary of enhancing physical or cognitive human capabilities? What to do with biological differences widening the gap of the haves and have-nots? Could we define where is the boundary to augment life? Will we sue robots or algorithms for medical malpractice? With the constant advancement of technology, unprecedented moral, ethical and legal concerns are surfacing. Channeling them into substantial debates will get us closer to their fair solution step by step. Here, we collected the most pressing issues in bioethics. Bioethicists of the world...
Source: The Medical Futurist - March 26, 2019 Category: Information Technology Authors: nora Tags: Bioethics Cyborgization Genomics bioethical data debate DNA future gene editing genetic genetics Innovation legal longevity medical medical data moral sex sexuality technology Source Type: blogs

Podcast: The Warning Signs of Bipolar and Schizophrenia
 In general, people with mental illness aren’t perfectly fine one day and suddenly symptomatic the next. It often feels that way to people with bipolar, depression, and schizophrenia, but many of us in recovery realize that the warning signs were there all along.    SUBSCRIBE & REVIEW “If you think there might be something wrong – that is a red flag.” – Gabe Howard   Highlights From ‘Warning Bipolar Schizophrenia’’ Episode [1:00] March 30th is World Bipolar Day! [2:30] What are some of the warning signs of mental illness? [5:00] Will supplements...
Source: World of Psychology - March 25, 2019 Category: Psychiatry & Psychology Authors: A Bipolar, a Schizophrenic, and a Podcast Tags: A Bipolar, A Schizophrenic, and a Podcast Disorders Schizophrenia Source Type: blogs

The Transparency International 2018 Corporate Political Engagement Index- Pharma Appears All Too Comfortable with the Revolving Door and Making Opaque Political Contributions
(Source: Health Care Renewal)
Source: Health Care Renewal - March 21, 2019 Category: Health Management Tags: AstraZeneca conflicts of interest dark money deception GlaxoSmithKline Johnson and Johnson Novartis Pfizer revolving doors Roche Shire Source Type: blogs

10 Reasons Why Digital Health Start-Ups Go Bust
While the digital health market is expanding rapidly, ninety percent of start-ups will probably die within two to five years from their inception. That’s an awfully high number, so we looked around what could possibly go wrong with digital health start-ups to avoid the undeserving fate of falling into the abyss. Being an entrepreneur is tough – especially in healthcare As currently there’s an app for everything, you thought you make one that estimates the time needed to deliver food – so anyone could order pad thai from the closest place possible. Every single entrepreneur knows that a good id...
Source: The Medical Futurist - March 14, 2019 Category: Information Technology Authors: nora Tags: Business Health Sensors & Trackers Healthcare Design business model companies digital health digital health startups entrepreneurship future healthcare data Innovation patient design scientific scientific validation technology Source Type: blogs

Multi-Parameter Sensors Detect Chemical and Physical Stimuli
Sensors are usually made to detect specific chemical or physical stimuli, making it difficult to create devices that can monitor a variety of different parameters at the same time. Now researchers at  Technion-Israel Institute of Technology have developed an unusual sensor, built  out of conductive ink formed into origami arrays, that can detect both chemical and physical stimuli. The device can measure the temperature, humidity, light, and the presence of volatile organic compounds. The technology is also impressive in that it can be used to tell apart isomers and chiral enantiomers of volatile organic com...
Source: Medgadget - March 13, 2019 Category: Medical Devices Authors: Editors Tags: Diagnostics Genetics News Source Type: blogs

Happy 14th birthday to the Health Business Blog
Happy 14th! My main job is president of Health Business Group, a boutique healthcare strategy consulting firm I founded in 2003. As a sideline, I write the Health Business Blog, where I provide a behind the scenes look at the business of healthcare, featuring my spin on healthcare topics in the news, interviews with entrepreneurs, and policy prescriptions. The blog is turning 14 years old this month!  Continuing a tradition I established with birthdays one,  two,  three,  four,  five,  six,  seven,  eight,  nine,  ten,&...
Source: Health Business Blog - March 12, 2019 Category: Health Management Authors: dewe67 Tags: Announcements Blogs Source Type: blogs

Physicians are now lab rats
Pay for performance (P4P) is all the rage in health care. Big Pharma led the way, and the popular press would have you believe that one can “incentivize” physicians and their clinical colleagues with as little as a sandwich and a bag of chips. Corporations have used bonuses, stock options, and commissions for years as […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - March 9, 2019 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/charles-dinerstein" rel="tag" > Charles Dinerstein, MD, MBA < /a > < /span > Tags: Policy Practice Management Public Health & Source Type: blogs

Interesting and important story on fecal transplants in @nytimes
This is definitely worth a read:Drug Companies and Doctors Battle Over the Future of Fecal Transplants - The New York Times. By Andrew Jacobs. March 3, 2019.The lead in is good:CAMBRIDGE, Mass. — There’s a new war raging in health care, with hundreds of millions of dollars at stake and thousands of lives in the balance. The battle, pitting drug companies against doctors and patient advocates, is being fought over the unlikeliest of substances: human excrement.The story is both interesting and includes some very important stuff going on behind the scenes that may affect the future of fecal transplants as a treat...
Source: The Tree of Life - March 5, 2019 Category: Microbiology Authors: Jonathan Eisen Source Type: blogs

#CareTalk February 2019: Medicare for All?
The latest edition of #CareTalk is out. CareCentrix CEO, John Driscoll and I explore Medicare for All and other big topics. Here’s what we covered: (0:35) Is “Medicare for All” quickly becoming a litmus test for Democratic presidential candidates? (2:45) What should be made of the recent moves of home health agencies around primary care? (5:00) Are pharma rebates to blame for increased drug pricing? (8:00) President Trump promised a whopping $50 million a year for childhood cancer. What would you do with all that money? (8:32) Will adding the full list price of drugs in ads make a difference? (9...
Source: Health Business Blog - February 28, 2019 Category: Health Management Authors: dewe67 Tags: Podcast Policy and politics #medicareforall Caretalk Source Type: blogs

TREMFYA One-Press Patient Controlled Injector Approved for Plaque Psoriasis
The Janssen Pharma, a part of Johnson & Johnson, won FDA approval for its TREMFYA One-Press single-dose injector. The device is used to deliver TREMFYA (guselkumab) as a treatment for moderate to severe plaque psoriasis. The TREMFYA One-Press allows patients to decide how fast and with how much pressure to deliver the medication. This lets everyone decide how much discomfort they will put up with, while everyone gets the required 100 mg during every injection. The needle is completely hidden and only comes out when the device is placed against the skin and activated. Physicians are expected to teach patients how ...
Source: Medgadget - February 27, 2019 Category: Medical Devices Authors: Editors Tags: Dermatology Medicine Source Type: blogs

Switching from Smoking to Juul Reduces Toxic Chemical Biomarkers to the Same Degree as Quitting Cold Turkey
This study adds to the already overwhelming evidence that vaping is much safer than smoking. And it further emphasizes the degree to which the Pennsylvania Department of Health is lying about the relative health effects of smoking vs. vaping. As I reported last week, the Pennsylvania Department of Health informs the public on itsweb site that: " E-cigarettes, also known as e-cigs, e-hookahs, mods, vape pens, vapes or ENDS,are not safer than other tobacco products for youth. "This study is significant because it didnot show that toxic chemical biomarker reduction with the Juul was at some level between continuing ...
Source: The Rest of the Story: Tobacco News Analysis and Commentary - February 27, 2019 Category: Addiction Source Type: blogs

Why Your Doctor Won ’ t Prescribe the T3 Thyroid Hormone
There is a simple reason why doctors typically refuse to prescribe the T3 thyroid hormone and it has nothing to do with science, side-effects, or potential dangers. As with so many things in healthcare, it boils down to Big Pharma and money. The solution is to find a better-informed doctor. The post Why Your Doctor Won’t Prescribe the T3 Thyroid Hormone appeared first on Dr. William Davis. (Source: Wheat Belly Blog)
Source: Wheat Belly Blog - February 26, 2019 Category: Cardiology Authors: Dr. Davis Tags: News & Updates cold hands feet fatigue hypothyroidism levothyroxine Synthroid t3 t4 tired undoctored wheat belly Wheat Belly Total Health Source Type: blogs

The Greediest Companies In American Healthcare Are Not Who You Think
There’s plenty of price gouging in American healthcare. The pharmaceutical industry has gotten plenty of (well deserved) bad press for its pricing practices. At the extreme are people like “Pharma Bro” (and convicted felon) Martin Shkreli, who hiked the price … Continue reading → The post The Greediest Companies In American Healthcare Are Not Who You Think appeared first on PeterUbel.com. (Source: blog.bioethics.net)
Source: blog.bioethics.net - February 25, 2019 Category: Medical Ethics Authors: PeterUbel.com Tags: Health Care Peter Ubel syndicated Uncategorized Source Type: blogs

Agenus plans digital security offering. PCG ’ s Jeff Ramson explains in this podcast
https://website.guild.im/williams/wp-content/uploads/sites/17/2019/02/agenus-token-offering-.mp3 Biotech company Agenus is launching a “digital security offering” that will let people invest directly in a single biotech product, rather than the whole company. Jeff Ramson, founder and CEO of strategic communications firm PCG Advisory Group, became fascinated by the concept and reached out to me to discuss it, even though he is not involved in the offering. (And neither am I.) In this podcast, we cover the following topics: Agenus is launching the first asset-backed digital security offering in healthcare. What...
Source: Health Business Blog - February 25, 2019 Category: Health Management Authors: dewe67 Tags: Pharma Podcast Source Type: blogs

The Revolving Door Spins Again: the Now Constant Coziness Between the Health Care Industry and US Government
Just because Washington DC is now crazy town does not mean the revolving door has stopped spinning.  We have been dutifully accumulating cases, so it is time to present our latest update.I will divide this into two sections 1) the incoming revolving door, through which come people from the health care industry to enter US government positions in which they may influence health care regulation or policy relevant to their former positions; and 2) the outgoing revolving door, through which go people from US government positions in which they influenced health care regulation or policy to industry positions which were rel...
Source: Health Care Renewal - February 22, 2019 Category: Health Management Tags: DHHS Donald Trump FDA revolving doors Source Type: blogs

The Surprising Truth About The Rising Price Of Generic Medications
In recent years, it feels like we’ve been inundated by stories of greedy pharmaceutical companies jacking up the price of important generic medications. In 2015, “Pharma Bro” Martin Shkreli, recognized that no other generic companies were manufacturing Daraprim, a drug … Continue reading → The post The Surprising Truth About The Rising Price Of Generic Medications appeared first on PeterUbel.com. (Source: blog.bioethics.net)
Source: blog.bioethics.net - February 22, 2019 Category: Medical Ethics Authors: PeterUbel.com Tags: Health Care Peter Ubel syndicated Uncategorized Source Type: blogs

THCB Spotlights: EyeforPharma
By ZOYA KHAN Jessica DaMassa interviews Paul Simms, the Chairman of Eyepharma. Eyeforpharma are the “media moguls” when it comes to the Pharma industry. In order to innovate the industry, they are holding two different conferences this year to bring pharma leaders and health technology startups together to foster relationships and strategic partnerships with one another. Their first conference will be held in Barcelona in March, and the second one will be in Philadelphia in April. Paul speaks to Jess about how health tech startups are maturing in their ways and realizing that health ca...
Source: The Health Care Blog - February 20, 2019 Category: Consumer Health News Authors: matthew holt Tags: Health Technology Pharmaceuticals THCB THCB Spotlights eyeforpharma health tech startups jessica da massa paul simms pharma innovation Pharmaceutical industry Source Type: blogs

Instagram Influencers Promote Prescription Drugs; FDA's Continuing Monitoring
The FDS has warned pharmaceutical companies in the past about their use of paid surrogates on social media sites like Instagram to promote their products (see:Pharmaceutical Companies Continue to Experiment with Social Media;FDA Issues Warning Letter to Drug Company about Use of Instagram;GlaxoSmithKline Mines Social Media for Information about Adverse Drug Events). This issue has recently returned to the news (see:The latest Instagram influencer frontier? Medical promotions. Big pharma is partnering with influencers to sell new drugs and medical devices). Below is an excerpt from the article. It's long and provides ma...
Source: Lab Soft News - February 20, 2019 Category: Laboratory Medicine Authors: Bruce Friedman Source Type: blogs

Spravato: New Ketamine Treatment to be Approved by FDA
Last week a committee of the U.S. Food and Drug Administration (FDA) recommended in a 14-2 vote that the agency approve the use of a nasal spray form of esketamine (a specific type of ketamine) for the treatment of treatment-resistant depression and certain other types of depression. Treatment-resistant depression is when clinical depression fails to respond to multiple (at least two) attempts to treat it with at least two different types of medications or psychotherapy over the course of a year or longer. If the FDA ends up approving the drug — and we believe they will — it will offer new hope for people with ...
Source: World of Psychology - February 20, 2019 Category: Psychiatry & Psychology Authors: John M. Grohol, Psy.D. Tags: Depression Disorders General Medications Treatment esketamine ketamine for depression Spravato Suicide TRD Treatment Resistant Depression Treatment-resistant Source Type: blogs

China Is Building The Ultimate Technological Health Paradise. Or Is It?
How could a country keep around 1.4 billion people healthy when the system struggles with corruption, lack of resources and an aging population? China, the emerging giant with a strong central leadership fostering technology and innovation, places its bets on artificial intelligence, telemedicine, cloud-based hospitals, and WeChat. While that could sound like an ultimate technological paradise, the question is, what are they going to do with the vast amount of data or to what interests are they going to leverage their state of the art A.I. systems? Generally, how will we speak about digital health in China: a healthcare dy...
Source: The Medical Futurist - February 19, 2019 Category: Information Technology Authors: nora Tags: Artificial Intelligence in Medicine Bioethics Future of Medicine Medical Professionals Patients Policy Makers AI chatbot china digital digital health Healthcare Innovation smartphone technology telehealth telemedicine Source Type: blogs

Depth Electrodes or Digital Biomarkers? The future of mood monitoring
Stereoelectroencephalography (SEEG) vs.Mindstrong HealthMood Monitoring via Invasive Brain Recordings or Smartphone SwipesWhich Would You Choose?That's not really a fair question. The ultimate goal of invasive recordings is one of direct intervention, by delivering targeted brain stimulation as a treatment. But first you have to establish a firm relationship between neural activity and mood. Well, um, smartphone swipes (the way you interact with your phone) aim to establish a firm relationship between your “digital phenotype” and your mood. And then refer you to an app for a precision intervention. Or to your t...
Source: The Neurocritic - February 19, 2019 Category: Neuroscience Authors: The Neurocritic Source Type: blogs

An Interview with Sebastian Aguiar of Apollo Ventures
Apollo Ventures is one of the first wave of investor concerns focused on the treatment of aging, and the principals and staff have put a fair amount of work into building a model for finding and commercializing promising research. They also publish the Geroscience popular science site, which is a helpful act of advocacy for the wider cause. As is the case for near all bigger venture funding organizations, they have a senolytics company (Cleara Biotech) in their portfolio, and thus the SENS model for rejuvenation is advanced. What initially attracted you to aging as a general discipline? Through multiple, or...
Source: Fight Aging! - February 8, 2019 Category: Research Authors: Reason Tags: Daily News Source Type: blogs

Where Is Digital Health Heading In Denmark?
After reading the Danish digital health strategy, one of the most forward-looking examples of a government-supported objective to adjust the medical arena to the 21st century, we looked around what real-life projects aim to transform patients’ and doctors’ lives for the better in the Scandinavian country. Our findings are thrilling: the newly established Danish National Genome Center strives to have at least 60,000 whole-genome sequenced in the next 5 years, while the Copenhagen Healthtech Cluster wants to set up a network of data registers updated so fast that it might enable helping doctors real-time – ...
Source: The Medical Futurist - February 7, 2019 Category: Information Technology Authors: nora Tags: Future of Medicine Healthcare Policy big data Danish Denmark digital health digital health strategy genetics genomics health data healthcare design Innovation technology Source Type: blogs

Thoughtful Discussion of Trump Administration Drug Pricing Plans
Discussion of Trump Administration Drug Pricing Plans appeared first on PeterUbel.com. (Source: blog.bioethics.net)
Source: blog.bioethics.net - February 6, 2019 Category: Medical Ethics Authors: PeterUbel.com Tags: Health Care health policy Peter Ubel syndicated Source Type: blogs

Ten reasons to NEVER eat gluten-free processed foods
. It saddens me: As popular as the Wheat Belly books and lifestyle have been, there are still millions of people who say things like “Oh, that Wheat Belly thing is just about being gluten-free.” They couldn’t be more wrong and have clearly not read any of the books. Yes, you can be gluten-free and consume foods that naturally have no gluten, gliadin, wheat germ agglutinin, amylopectin A, phytates, and the rest of the toxic components contained in wheat and related grains. You can eat apples, bacon, eggs, and salmon that are naturally gluten-free. You can drink water or tea that is gluten-free. No problems...
Source: Wheat Belly Blog - February 1, 2019 Category: Cardiology Authors: Dr. Davis Tags: News & Updates gluten gluten-free grain-free grains wheat belly Source Type: blogs

A real national emergency
Actually there are a few of them butRajan Menon offers a good, succinct discussion of the opioid epidemic. When a few fanatics hijacked airliners and flew them into buildings, killing about 3,000 people, the U.S. went on a nearly two decade freakout. Since then, 400,000 Americans have died from prescription or illicit opioid overdoses, some 70,000 of them in 2017.Individual 1 did indeed declare a public health emergency in that year, but never actually did anything about it. Congress did appropriate $6 billion a year to combat the crisis, but that has had no discernible effect. And let's be clear here: illicit drugs do not...
Source: Stayin' Alive - January 31, 2019 Category: American Health Source Type: blogs

Annual Pharmaceutical Microbiology Conference
June 05 - 06, 2019 SMI: 3rd Annual Pharmaceutical Microbiology West Coast San Diego, USA Further information www.pharma-microbiology-usa.com/microbiologyconf SMi's 3rd Annual Pharmaceutical Microbiology West Coast. The pharmaceutical microbiology field is an ever-present constant in almost all areas of pharmaceuticals. We are experiencing a period of rapid change, with new regulatory considerations to implement into our environmental monitoring programmes, new technologies to improve processes and novel validation techniques. Some of the topics that this conference will cover: risk-based approaches to aseptic processing, m...
Source: Microbiology Blog: The weblog for microbiologists. - January 31, 2019 Category: Microbiology Source Type: blogs

More Than Just Dander
First, a sort of meta-comment in the form of a shout-out to HCRenewal's intrepid editor, Dr. Roy Poses, for his just-published analysis of what we might call " blogging: rise and fall. " He sees decline reflected in publications long  devoted to health and health policy, yet now flaking off.Methinks, however, despite the usefulness of his overview of recent decades, Dr. P need not fret excessively. Water spilling out of the barrel's lip will slow down once folks come along and punch a whole bunch of little mid-section tweet-holes in it. Information still flows. (Sort of.)  In any case, surely there's ov...
Source: Health Care Renewal - January 25, 2019 Category: Health Management Source Type: blogs

A Digitally Caring Environment: The Internet of Things in Hospitals
What do hospital beds tell about patients? How does an „indoor GPS”-system work? How could sensors and connected devices enhance both patient experience and medical resource efficiency? Here, we tell you everything about IoT within the walls of health facilities. Emergency drones, Fitbits, and chatty hospital-beds In April 2045, Paul was walking down the street with her 4-year-old daughter, Lily, in downtown Boston. They were heading to the ice cream & deli at the corner of the square two minutes from their home. Suddenly, the man experienced chest pain, started to breathe heavily and collapsed. Lily looked...
Source: The Medical Futurist - January 24, 2019 Category: Information Technology Authors: nora Tags: Future of Medicine Health Sensors & Trackers Healthcare Design AI connected digital digital health digital health sensors doctor future of hospital IoT patient smart smart algorithm Source Type: blogs

A Digitally Caring Environment: The Internet of Things in Hospitals
What do hospital beds tell about patients? How does an „indoor GPS”-system work? How could sensors and connected devices enhance both patient experience and medical resource efficiency? Here, we tell you everything about IoT within the walls of health facilities. Emergency drones, Fitbits, and chatty hospital-beds In April 2045, Paul was walking down the street with her 4-year-old daughter, Lily, in downtown Boston. They were heading to the ice cream & deli at the corner of the square two minutes from their home. Suddenly, the man experienced chest pain, started to breathe heavily and collapsed. Lily looked...
Source: The Medical Futurist - January 24, 2019 Category: Information Technology Authors: nora Tags: Future of Medicine Health Sensors & Trackers Healthcare Design AI connected digital digital health digital health sensors doctor future of hospital IoT patient smart smart algorithm Source Type: blogs

No Pain, No Gain: R & D Challenges for Success of Microneedle Systems
Conclusion Healthcare systems and patients increasingly make use of additional sensor data to monitor conditions and personalise treatments. The industry is also focussing on adherence to treatment as a key driver of improved health outcomes. And novel biologic drugs require different drug delivery systems for maximum effectiveness. Microneedle technology offers exciting prospects in all these areas, with the potential to transform patient outcomes. Based on experience with microfluidic medical devices, we suggest that successful microneedle system development requires focus on application consistency, consideration of the...
Source: Medgadget - January 21, 2019 Category: Medical Devices Authors: Editors Tags: Sponsored Content Source Type: blogs